Misuse of Ozempic and Other Diabetes Drugs for Weight Loss: Delhi High Court Directs CDSCO to Respond
6 Articles
6 Articles
Delhi HC Asks DGCI to Decide Representation over Weight-loss Drugs
Get latest articles and stories on India at LatestLY. The Delhi High Court on Wednesday asked the Drug Controller General of India to consult experts and relevant stakeholders in deciding a plea over drug combinations sold in the market for weight loss treatment. India News | Delhi HC Asks DGCI to Decide Representation over Weight-loss Drugs.
Delhi HC Directs DCGI To Decide On Plea Flagging Concerns Over Approvals Of Weight Loss Drugs
The Delhi High Court directed the drug controller general of India on Wednesday to decide on a plea flagging weight loss medicines in three months.The court disposed of a public interest litigation that flagged concerns over the current system of approval of drug combinations used in weight management treatments, NDTV reported.A bench of Chief Justice DK Upadhyaya and Justice Tushar Rao Gedela asked the petitioner to submit a formal representati…
‘Decide within 3 months’: Delhi HC tells CDSCO on plea against use of diabetes drugs in weight management
New Delhi: The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 months, a representation raising safety concerns on the usage of...
‘Decide within 3 months’: Delhi HC tells CDSCO on plea against use...
Last Updated on July 2, 2025 by Team THIP New Delhi, July 2 (IANS) The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 months, a representation raising safety concerns on the usage of GLP-1-RA drugs in weight management and aesthetic treatment. A bench of Chief Justice […] The post ‘Decide within 3 months’: Delhi HC tells CDSCO on plea against use of diabetes drugs in weight mana…
Coverage Details
Bias Distribution
- 33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
To view factuality data please Upgrade to Premium